nodes	percent_of_prediction	percent_of_DWPC	metapath
Lomitapide—P-Glycoprotein Inhibitors—Everolimus—kidney cancer	0.22	0.352	CiPCiCtD
Lomitapide—Cytochrome P450 3A4 Inhibitors—Pazopanib—kidney cancer	0.202	0.324	CiPCiCtD
Lomitapide—Cytochrome P450 3A4 Inhibitors—Everolimus—kidney cancer	0.202	0.324	CiPCiCtD
Lomitapide—ABCB1—kidney cancer	0.107	1	CbGaD
Lomitapide—ABCB1—Temsirolimus—kidney cancer	0.0228	0.134	CbGbCtD
Lomitapide—CYP3A4—Everolimus—kidney cancer	0.0202	0.119	CbGbCtD
Lomitapide—CYP3A4—Temsirolimus—kidney cancer	0.0136	0.0802	CbGbCtD
Lomitapide—ABCB1—Pazopanib—kidney cancer	0.012	0.0703	CbGbCtD
Lomitapide—ABCB1—Dactinomycin—kidney cancer	0.0109	0.0643	CbGbCtD
Lomitapide—ABCB1—Gemcitabine—kidney cancer	0.00865	0.0509	CbGbCtD
Lomitapide—ABCB1—Erlotinib—kidney cancer	0.00853	0.0502	CbGbCtD
Lomitapide—ABCB1—Paclitaxel—kidney cancer	0.00781	0.046	CbGbCtD
Lomitapide—CYP3A4—Pazopanib—kidney cancer	0.00717	0.0422	CbGbCtD
Lomitapide—ABCB1—Sorafenib—kidney cancer	0.00694	0.0408	CbGbCtD
Lomitapide—ABCB1—Vinblastine—kidney cancer	0.00685	0.0403	CbGbCtD
Lomitapide—ABCB1—Vincristine—kidney cancer	0.00674	0.0396	CbGbCtD
Lomitapide—ABCB1—Sunitinib—kidney cancer	0.00562	0.0331	CbGbCtD
Lomitapide—CYP3A4—Erlotinib—kidney cancer	0.00511	0.0301	CbGbCtD
Lomitapide—CYP3A4—Paclitaxel—kidney cancer	0.00468	0.0275	CbGbCtD
Lomitapide—ABCB1—Doxorubicin—kidney cancer	0.00421	0.0248	CbGbCtD
Lomitapide—CYP3A4—Sorafenib—kidney cancer	0.00416	0.0245	CbGbCtD
Lomitapide—CYP3A4—Vinblastine—kidney cancer	0.00411	0.0241	CbGbCtD
Lomitapide—CYP3A4—Vincristine—kidney cancer	0.00404	0.0237	CbGbCtD
Lomitapide—CYP3A4—Sunitinib—kidney cancer	0.00337	0.0198	CbGbCtD
Lomitapide—CYP3A4—Doxorubicin—kidney cancer	0.00252	0.0148	CbGbCtD
Lomitapide—MTTP—nephron tubule—kidney cancer	0.00249	0.212	CbGeAlD
Lomitapide—MTTP—renal system—kidney cancer	0.00227	0.192	CbGeAlD
Lomitapide—MTTP—kidney—kidney cancer	0.00219	0.186	CbGeAlD
Lomitapide—MTTP—cortex of kidney—kidney cancer	0.00213	0.181	CbGeAlD
Lomitapide—CYP3A4—urine—kidney cancer	0.00116	0.0981	CbGeAlD
Lomitapide—MTTP—Statin Pathway—SCARB1—kidney cancer	0.000662	0.096	CbGpPWpGaD
Lomitapide—Antrafenine—PTGS1—kidney cancer	0.000654	0.568	CrCbGaD
Lomitapide—MTTP—Lipoprotein metabolism—SCARB1—kidney cancer	0.000644	0.0934	CbGpPWpGaD
Lomitapide—MTTP—Lipid and lipoprotein metabolism—SCARB1—kidney cancer	0.000428	0.0621	CbGpPWpGaD
Lomitapide—Antrafenine—PTGS2—kidney cancer	0.000374	0.325	CrCbGaD
Lomitapide—CYP3A4—renal system—kidney cancer	0.000283	0.024	CbGeAlD
Lomitapide—CYP3A4—kidney—kidney cancer	0.000273	0.0232	CbGeAlD
Lomitapide—ABCB1—nephron tubule—kidney cancer	0.00022	0.0187	CbGeAlD
Lomitapide—MTTP—Circadian rythm related genes—HNF1B—kidney cancer	0.000206	0.0299	CbGpPWpGaD
Lomitapide—CYP3A4—Aflatoxin activation and detoxification—ACY1—kidney cancer	0.000205	0.0298	CbGpPWpGaD
Lomitapide—MTTP—Circadian rythm related genes—KCNMA1—kidney cancer	0.000201	0.0291	CbGpPWpGaD
Lomitapide—ABCB1—renal system—kidney cancer	0.0002	0.017	CbGeAlD
Lomitapide—ABCB1—kidney—kidney cancer	0.000193	0.0164	CbGeAlD
Lomitapide—ABCB1—cortex of kidney—kidney cancer	0.000188	0.016	CbGeAlD
Lomitapide—MTTP—Circadian rythm related genes—JUND—kidney cancer	0.00018	0.0261	CbGpPWpGaD
Lomitapide—ABCB1—gonad—kidney cancer	0.000179	0.0152	CbGeAlD
Lomitapide—MTTP—Metabolism of lipids and lipoproteins—GLIPR1—kidney cancer	0.000139	0.0202	CbGpPWpGaD
Lomitapide—CYP3A4—Fatty Acid Omega Oxidation—ALDH1A1—kidney cancer	0.000129	0.0187	CbGpPWpGaD
Lomitapide—Fexofenadine—ABCB1—kidney cancer	0.000124	0.108	CrCbGaD
Lomitapide—MTTP—Circadian rythm related genes—EGR1—kidney cancer	0.000115	0.0166	CbGpPWpGaD
Lomitapide—ABCB1—Allograft Rejection—HARS—kidney cancer	0.000107	0.0154	CbGpPWpGaD
Lomitapide—CYP3A4—Aflatoxin B1 metabolism—GSTM1—kidney cancer	9.36e-05	0.0136	CbGpPWpGaD
Lomitapide—MTTP—Metabolism—ACY1—kidney cancer	8.94e-05	0.013	CbGpPWpGaD
Lomitapide—CYP3A4—Codeine and Morphine Metabolism—ABCB1—kidney cancer	8.67e-05	0.0126	CbGpPWpGaD
Lomitapide—MTTP—Metabolism of lipids and lipoproteins—CRABP1—kidney cancer	7.63e-05	0.0111	CbGpPWpGaD
Lomitapide—MTTP—Metabolism—PDHB—kidney cancer	7.6e-05	0.011	CbGpPWpGaD
Lomitapide—CYP3A4—Irinotecan Pathway—BCHE—kidney cancer	7.35e-05	0.0107	CbGpPWpGaD
Lomitapide—CYP3A4—Benzo(a)pyrene metabolism—CYP1A1—kidney cancer	7.26e-05	0.0105	CbGpPWpGaD
Lomitapide—MTTP—Metabolism—CCBL1—kidney cancer	7.15e-05	0.0104	CbGpPWpGaD
Lomitapide—ABCB1—HIF-1-alpha transcription factor network—PGK1—kidney cancer	6.47e-05	0.00937	CbGpPWpGaD
Lomitapide—MTTP—Metabolism of lipids and lipoproteins—ACHE—kidney cancer	6.46e-05	0.00937	CbGpPWpGaD
Lomitapide—MTTP—Metabolism—PPAT—kidney cancer	6.2e-05	0.00898	CbGpPWpGaD
Lomitapide—MTTP—Metabolism—GLIPR1—kidney cancer	6.2e-05	0.00898	CbGpPWpGaD
Lomitapide—ABCB1—Allograft Rejection—LRRK2—kidney cancer	6.12e-05	0.00887	CbGpPWpGaD
Lomitapide—MTTP—Metabolism of lipids and lipoproteins—SCARB1—kidney cancer	6.12e-05	0.00887	CbGpPWpGaD
Lomitapide—MTTP—Metabolism of lipids and lipoproteins—PTGS1—kidney cancer	6.06e-05	0.00878	CbGpPWpGaD
Lomitapide—ABCB1—HIF-1-alpha transcription factor network—NDRG1—kidney cancer	6.01e-05	0.00871	CbGpPWpGaD
Lomitapide—Malaise—Gemcitabine—kidney cancer	5.81e-05	0.000745	CcSEcCtD
Lomitapide—Eye disorder—Paclitaxel—kidney cancer	5.79e-05	0.000743	CcSEcCtD
Lomitapide—Myalgia—Vincristine—kidney cancer	5.78e-05	0.000742	CcSEcCtD
Lomitapide—Dyspepsia—Sunitinib—kidney cancer	5.76e-05	0.00074	CcSEcCtD
Lomitapide—MTTP—Metabolism—APRT—kidney cancer	5.76e-05	0.00835	CbGpPWpGaD
Lomitapide—MTTP—Metabolism—FH—kidney cancer	5.76e-05	0.00835	CbGpPWpGaD
Lomitapide—Cardiac disorder—Paclitaxel—kidney cancer	5.75e-05	0.000738	CcSEcCtD
Lomitapide—Weight decreased—Capecitabine—kidney cancer	5.74e-05	0.000737	CcSEcCtD
Lomitapide—Decreased appetite—Sunitinib—kidney cancer	5.69e-05	0.000731	CcSEcCtD
Lomitapide—Infestation—Capecitabine—kidney cancer	5.66e-05	0.000727	CcSEcCtD
Lomitapide—Infestation NOS—Capecitabine—kidney cancer	5.66e-05	0.000727	CcSEcCtD
Lomitapide—Gastrointestinal disorder—Sunitinib—kidney cancer	5.65e-05	0.000726	CcSEcCtD
Lomitapide—Musculoskeletal discomfort—Dactinomycin—kidney cancer	5.65e-05	0.000725	CcSEcCtD
Lomitapide—Asthenia—Vinblastine—kidney cancer	5.65e-05	0.000725	CcSEcCtD
Lomitapide—Fatigue—Sunitinib—kidney cancer	5.65e-05	0.000725	CcSEcCtD
Lomitapide—MTTP—Metabolism of lipids and lipoproteins—BCHE—kidney cancer	5.63e-05	0.00816	CbGpPWpGaD
Lomitapide—Asthenia—Everolimus—kidney cancer	5.62e-05	0.000722	CcSEcCtD
Lomitapide—Constipation—Sunitinib—kidney cancer	5.6e-05	0.000719	CcSEcCtD
Lomitapide—Mediastinal disorder—Paclitaxel—kidney cancer	5.58e-05	0.000716	CcSEcCtD
Lomitapide—Gastrointestinal pain—Sorafenib—kidney cancer	5.56e-05	0.000714	CcSEcCtD
Lomitapide—Chills—Paclitaxel—kidney cancer	5.56e-05	0.000713	CcSEcCtD
Lomitapide—CYP3A4—Tryptophan metabolism—ALDH1A1—kidney cancer	5.55e-05	0.00804	CbGpPWpGaD
Lomitapide—Infection—Vincristine—kidney cancer	5.5e-05	0.000706	CcSEcCtD
Lomitapide—ABCB1—HIF-1-alpha transcription factor network—CA9—kidney cancer	5.5e-05	0.00797	CbGpPWpGaD
Lomitapide—Arthralgia—Gemcitabine—kidney cancer	5.48e-05	0.000704	CcSEcCtD
Lomitapide—Chest pain—Gemcitabine—kidney cancer	5.48e-05	0.000704	CcSEcCtD
Lomitapide—Myalgia—Gemcitabine—kidney cancer	5.48e-05	0.000704	CcSEcCtD
Lomitapide—Blood alkaline phosphatase increased—Doxorubicin—kidney cancer	5.44e-05	0.000699	CcSEcCtD
Lomitapide—Unspecified disorder of skin and subcutaneous tissue—Gemcitabine—kidney cancer	5.44e-05	0.000699	CcSEcCtD
Lomitapide—Nervous system disorder—Vincristine—kidney cancer	5.43e-05	0.000697	CcSEcCtD
Lomitapide—Asthenia—Erlotinib—kidney cancer	5.43e-05	0.000697	CcSEcCtD
Lomitapide—MTTP—Metabolism—GPC3—kidney cancer	5.42e-05	0.00785	CbGpPWpGaD
Lomitapide—Discomfort—Gemcitabine—kidney cancer	5.41e-05	0.000695	CcSEcCtD
Lomitapide—Haematuria—Capecitabine—kidney cancer	5.4e-05	0.000693	CcSEcCtD
Lomitapide—Malnutrition—Paclitaxel—kidney cancer	5.39e-05	0.000692	CcSEcCtD
Lomitapide—Decreased appetite—Dactinomycin—kidney cancer	5.39e-05	0.000692	CcSEcCtD
Lomitapide—Diarrhoea—Vinblastine—kidney cancer	5.38e-05	0.000691	CcSEcCtD
Lomitapide—Abdominal pain—Sorafenib—kidney cancer	5.38e-05	0.000691	CcSEcCtD
Lomitapide—Body temperature increased—Sorafenib—kidney cancer	5.38e-05	0.000691	CcSEcCtD
Lomitapide—Diarrhoea—Everolimus—kidney cancer	5.36e-05	0.000689	CcSEcCtD
Lomitapide—Gastrointestinal pain—Sunitinib—kidney cancer	5.35e-05	0.000687	CcSEcCtD
Lomitapide—Hyperhidrosis—Vincristine—kidney cancer	5.35e-05	0.000687	CcSEcCtD
Lomitapide—Hepatobiliary disease—Capecitabine—kidney cancer	5.35e-05	0.000687	CcSEcCtD
Lomitapide—Fatigue—Dactinomycin—kidney cancer	5.34e-05	0.000686	CcSEcCtD
Lomitapide—Flatulence—Paclitaxel—kidney cancer	5.31e-05	0.000682	CcSEcCtD
Lomitapide—MTTP—Metabolism—CA2—kidney cancer	5.27e-05	0.00764	CbGpPWpGaD
Lomitapide—Infection—Gemcitabine—kidney cancer	5.22e-05	0.00067	CcSEcCtD
Lomitapide—Back pain—Paclitaxel—kidney cancer	5.21e-05	0.000669	CcSEcCtD
Lomitapide—Dizziness—Vinblastine—kidney cancer	5.2e-05	0.000668	CcSEcCtD
Lomitapide—Dizziness—Everolimus—kidney cancer	5.18e-05	0.000665	CcSEcCtD
Lomitapide—Muscle spasms—Paclitaxel—kidney cancer	5.18e-05	0.000665	CcSEcCtD
Lomitapide—Abdominal pain—Sunitinib—kidney cancer	5.18e-05	0.000665	CcSEcCtD
Lomitapide—Body temperature increased—Sunitinib—kidney cancer	5.18e-05	0.000665	CcSEcCtD
Lomitapide—Diarrhoea—Erlotinib—kidney cancer	5.18e-05	0.000664	CcSEcCtD
Lomitapide—Nervous system disorder—Gemcitabine—kidney cancer	5.15e-05	0.000661	CcSEcCtD
Lomitapide—MTTP—Metabolism—ALAD—kidney cancer	5.14e-05	0.00744	CbGpPWpGaD
Lomitapide—Feeling abnormal—Dactinomycin—kidney cancer	5.11e-05	0.000656	CcSEcCtD
Lomitapide—Skin disorder—Gemcitabine—kidney cancer	5.1e-05	0.000655	CcSEcCtD
Lomitapide—Hyperhidrosis—Gemcitabine—kidney cancer	5.08e-05	0.000652	CcSEcCtD
Lomitapide—Gastrointestinal pain—Dactinomycin—kidney cancer	5.07e-05	0.000651	CcSEcCtD
Lomitapide—Musculoskeletal discomfort—Vincristine—kidney cancer	5.05e-05	0.000648	CcSEcCtD
Lomitapide—Increased appetite—Doxorubicin—kidney cancer	5.04e-05	0.000647	CcSEcCtD
Lomitapide—Urinary tract disorder—Capecitabine—kidney cancer	5.02e-05	0.000644	CcSEcCtD
Lomitapide—MTTP—Metabolism—ST3GAL2—kidney cancer	5.01e-05	0.00726	CbGpPWpGaD
Lomitapide—Vomiting—Vinblastine—kidney cancer	5e-05	0.000642	CcSEcCtD
Lomitapide—Dizziness—Erlotinib—kidney cancer	5e-05	0.000642	CcSEcCtD
Lomitapide—Ill-defined disorder—Paclitaxel—kidney cancer	5e-05	0.000642	CcSEcCtD
Lomitapide—Connective tissue disorder—Capecitabine—kidney cancer	4.99e-05	0.000641	CcSEcCtD
Lomitapide—Vomiting—Everolimus—kidney cancer	4.98e-05	0.00064	CcSEcCtD
Lomitapide—Anaemia—Paclitaxel—kidney cancer	4.98e-05	0.00064	CcSEcCtD
Lomitapide—Urethral disorder—Capecitabine—kidney cancer	4.98e-05	0.000639	CcSEcCtD
Lomitapide—Paraesthesia—Vincristine—kidney cancer	4.97e-05	0.000638	CcSEcCtD
Lomitapide—Dermatitis bullous—Doxorubicin—kidney cancer	4.95e-05	0.000636	CcSEcCtD
Lomitapide—Headache—Vinblastine—kidney cancer	4.93e-05	0.000633	CcSEcCtD
Lomitapide—Headache—Everolimus—kidney cancer	4.91e-05	0.00063	CcSEcCtD
Lomitapide—Abdominal pain—Dactinomycin—kidney cancer	4.9e-05	0.000629	CcSEcCtD
Lomitapide—Body temperature increased—Dactinomycin—kidney cancer	4.9e-05	0.000629	CcSEcCtD
Lomitapide—MTTP—Metabolism—ALDH1A1—kidney cancer	4.9e-05	0.0071	CbGpPWpGaD
Lomitapide—Asthenia—Sorafenib—kidney cancer	4.88e-05	0.000627	CcSEcCtD
Lomitapide—Malaise—Paclitaxel—kidney cancer	4.86e-05	0.000624	CcSEcCtD
Lomitapide—Vertigo—Paclitaxel—kidney cancer	4.84e-05	0.000622	CcSEcCtD
Lomitapide—Decreased appetite—Vincristine—kidney cancer	4.81e-05	0.000618	CcSEcCtD
Lomitapide—MTTP—Circadian rythm related genes—JUN—kidney cancer	4.81e-05	0.00697	CbGpPWpGaD
Lomitapide—Vomiting—Erlotinib—kidney cancer	4.81e-05	0.000617	CcSEcCtD
Lomitapide—Musculoskeletal discomfort—Gemcitabine—kidney cancer	4.79e-05	0.000615	CcSEcCtD
Lomitapide—Gastrointestinal disorder—Vincristine—kidney cancer	4.78e-05	0.000614	CcSEcCtD
Lomitapide—Fatigue—Vincristine—kidney cancer	4.77e-05	0.000613	CcSEcCtD
Lomitapide—Palpitations—Paclitaxel—kidney cancer	4.76e-05	0.000611	CcSEcCtD
Lomitapide—Eye disorder—Capecitabine—kidney cancer	4.75e-05	0.00061	CcSEcCtD
Lomitapide—CYP3A4—Drug Induction of Bile Acid Pathway—ABCB1—kidney cancer	4.74e-05	0.00687	CbGpPWpGaD
Lomitapide—Headache—Erlotinib—kidney cancer	4.74e-05	0.000608	CcSEcCtD
Lomitapide—Constipation—Vincristine—kidney cancer	4.74e-05	0.000608	CcSEcCtD
Lomitapide—Pain in extremity—Doxorubicin—kidney cancer	4.73e-05	0.000608	CcSEcCtD
Lomitapide—Paraesthesia—Gemcitabine—kidney cancer	4.72e-05	0.000606	CcSEcCtD
Lomitapide—Cardiac disorder—Capecitabine—kidney cancer	4.72e-05	0.000605	CcSEcCtD
Lomitapide—Asthenia—Sunitinib—kidney cancer	4.7e-05	0.000603	CcSEcCtD
Lomitapide—MTTP—Metabolism—SLC5A3—kidney cancer	4.7e-05	0.00681	CbGpPWpGaD
Lomitapide—MTTP—Metabolism—PGK1—kidney cancer	4.7e-05	0.00681	CbGpPWpGaD
Lomitapide—Nausea—Vinblastine—kidney cancer	4.67e-05	0.0006	CcSEcCtD
Lomitapide—Somnolence—Gemcitabine—kidney cancer	4.67e-05	0.0006	CcSEcCtD
Lomitapide—Migraine—Doxorubicin—kidney cancer	4.66e-05	0.000598	CcSEcCtD
Lomitapide—Nausea—Everolimus—kidney cancer	4.66e-05	0.000598	CcSEcCtD
Lomitapide—Diarrhoea—Sorafenib—kidney cancer	4.66e-05	0.000598	CcSEcCtD
Lomitapide—MTTP—Circadian rythm related genes—PTEN—kidney cancer	4.65e-05	0.00675	CbGpPWpGaD
Lomitapide—MTTP—Metabolism—LDHB—kidney cancer	4.61e-05	0.00668	CbGpPWpGaD
Lomitapide—Chest pain—Paclitaxel—kidney cancer	4.59e-05	0.000589	CcSEcCtD
Lomitapide—Myalgia—Paclitaxel—kidney cancer	4.59e-05	0.000589	CcSEcCtD
Lomitapide—Arthralgia—Paclitaxel—kidney cancer	4.59e-05	0.000589	CcSEcCtD
Lomitapide—CYP3A4—Fatty Acid Omega Oxidation—CYP1A1—kidney cancer	4.58e-05	0.00664	CbGpPWpGaD
Lomitapide—Mediastinal disorder—Capecitabine—kidney cancer	4.58e-05	0.000588	CcSEcCtD
Lomitapide—Decreased appetite—Gemcitabine—kidney cancer	4.57e-05	0.000586	CcSEcCtD
Lomitapide—Chills—Capecitabine—kidney cancer	4.56e-05	0.000585	CcSEcCtD
Lomitapide—Unspecified disorder of skin and subcutaneous tissue—Paclitaxel—kidney cancer	4.56e-05	0.000585	CcSEcCtD
Lomitapide—Gastrointestinal disorder—Gemcitabine—kidney cancer	4.54e-05	0.000582	CcSEcCtD
Lomitapide—Discomfort—Paclitaxel—kidney cancer	4.53e-05	0.000582	CcSEcCtD
Lomitapide—Fatigue—Gemcitabine—kidney cancer	4.53e-05	0.000582	CcSEcCtD
Lomitapide—Gastrointestinal pain—Vincristine—kidney cancer	4.53e-05	0.000581	CcSEcCtD
Lomitapide—Dizziness—Sorafenib—kidney cancer	4.5e-05	0.000578	CcSEcCtD
Lomitapide—Constipation—Gemcitabine—kidney cancer	4.49e-05	0.000577	CcSEcCtD
Lomitapide—Nausea—Erlotinib—kidney cancer	4.49e-05	0.000577	CcSEcCtD
Lomitapide—Dry mouth—Paclitaxel—kidney cancer	4.49e-05	0.000576	CcSEcCtD
Lomitapide—Diarrhoea—Sunitinib—kidney cancer	4.48e-05	0.000575	CcSEcCtD
Lomitapide—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—FLT1—kidney cancer	4.48e-05	0.00649	CbGpPWpGaD
Lomitapide—Asthenia—Dactinomycin—kidney cancer	4.45e-05	0.000571	CcSEcCtD
Lomitapide—Malnutrition—Capecitabine—kidney cancer	4.42e-05	0.000568	CcSEcCtD
Lomitapide—Dehydration—Doxorubicin—kidney cancer	4.4e-05	0.000565	CcSEcCtD
Lomitapide—CYP3A4—Estrogen metabolism—GSTM1—kidney cancer	4.4e-05	0.00637	CbGpPWpGaD
Lomitapide—Abdominal pain—Vincristine—kidney cancer	4.38e-05	0.000562	CcSEcCtD
Lomitapide—Body temperature increased—Vincristine—kidney cancer	4.38e-05	0.000562	CcSEcCtD
Lomitapide—Liver function test abnormal—Doxorubicin—kidney cancer	4.37e-05	0.000561	CcSEcCtD
Lomitapide—Infection—Paclitaxel—kidney cancer	4.37e-05	0.000561	CcSEcCtD
Lomitapide—Flatulence—Capecitabine—kidney cancer	4.36e-05	0.00056	CcSEcCtD
Lomitapide—Dry skin—Doxorubicin—kidney cancer	4.34e-05	0.000557	CcSEcCtD
Lomitapide—Dizziness—Sunitinib—kidney cancer	4.33e-05	0.000556	CcSEcCtD
Lomitapide—Feeling abnormal—Gemcitabine—kidney cancer	4.33e-05	0.000556	CcSEcCtD
Lomitapide—Vomiting—Sorafenib—kidney cancer	4.33e-05	0.000555	CcSEcCtD
Lomitapide—Abdominal pain upper—Doxorubicin—kidney cancer	4.32e-05	0.000555	CcSEcCtD
Lomitapide—Nervous system disorder—Paclitaxel—kidney cancer	4.31e-05	0.000554	CcSEcCtD
Lomitapide—Back pain—Capecitabine—kidney cancer	4.28e-05	0.000549	CcSEcCtD
Lomitapide—Skin disorder—Paclitaxel—kidney cancer	4.27e-05	0.000549	CcSEcCtD
Lomitapide—Aspartate aminotransferase increased—Doxorubicin—kidney cancer	4.26e-05	0.000547	CcSEcCtD
Lomitapide—Headache—Sorafenib—kidney cancer	4.26e-05	0.000547	CcSEcCtD
Lomitapide—Muscle spasms—Capecitabine—kidney cancer	4.25e-05	0.000546	CcSEcCtD
Lomitapide—Hyperhidrosis—Paclitaxel—kidney cancer	4.25e-05	0.000546	CcSEcCtD
Lomitapide—Diarrhoea—Dactinomycin—kidney cancer	4.24e-05	0.000544	CcSEcCtD
Lomitapide—Nasopharyngitis—Doxorubicin—kidney cancer	4.23e-05	0.000543	CcSEcCtD
Lomitapide—Gastritis—Doxorubicin—kidney cancer	4.19e-05	0.000538	CcSEcCtD
Lomitapide—Alanine aminotransferase increased—Doxorubicin—kidney cancer	4.18e-05	0.000536	CcSEcCtD
Lomitapide—CYP3A4—Estrogen metabolism—CYP1A1—kidney cancer	4.17e-05	0.00604	CbGpPWpGaD
Lomitapide—Vomiting—Sunitinib—kidney cancer	4.16e-05	0.000534	CcSEcCtD
Lomitapide—Body temperature increased—Gemcitabine—kidney cancer	4.15e-05	0.000533	CcSEcCtD
Lomitapide—Abdominal distension—Doxorubicin—kidney cancer	4.12e-05	0.000529	CcSEcCtD
Lomitapide—Ill-defined disorder—Capecitabine—kidney cancer	4.1e-05	0.000527	CcSEcCtD
Lomitapide—Headache—Sunitinib—kidney cancer	4.1e-05	0.000527	CcSEcCtD
Lomitapide—Influenza—Doxorubicin—kidney cancer	4.09e-05	0.000525	CcSEcCtD
Lomitapide—Anaemia—Capecitabine—kidney cancer	4.09e-05	0.000525	CcSEcCtD
Lomitapide—Nausea—Sorafenib—kidney cancer	4.04e-05	0.000519	CcSEcCtD
Lomitapide—Musculoskeletal discomfort—Paclitaxel—kidney cancer	4.01e-05	0.000514	CcSEcCtD
Lomitapide—MTTP—Metabolism—CA9—kidney cancer	3.99e-05	0.00579	CbGpPWpGaD
Lomitapide—CYP3A4—Irinotecan Pathway—APC—kidney cancer	3.99e-05	0.00579	CbGpPWpGaD
Lomitapide—Malaise—Capecitabine—kidney cancer	3.99e-05	0.000512	CcSEcCtD
Lomitapide—Angina pectoris—Doxorubicin—kidney cancer	3.99e-05	0.000512	CcSEcCtD
Lomitapide—Vertigo—Capecitabine—kidney cancer	3.97e-05	0.00051	CcSEcCtD
Lomitapide—Asthenia—Vincristine—kidney cancer	3.97e-05	0.00051	CcSEcCtD
Lomitapide—Paraesthesia—Paclitaxel—kidney cancer	3.95e-05	0.000507	CcSEcCtD
Lomitapide—Vomiting—Dactinomycin—kidney cancer	3.94e-05	0.000506	CcSEcCtD
Lomitapide—Somnolence—Paclitaxel—kidney cancer	3.91e-05	0.000502	CcSEcCtD
Lomitapide—Palpitations—Capecitabine—kidney cancer	3.91e-05	0.000502	CcSEcCtD
Lomitapide—MTTP—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	3.9e-05	0.00566	CbGpPWpGaD
Lomitapide—Nausea—Sunitinib—kidney cancer	3.89e-05	0.000499	CcSEcCtD
Lomitapide—Dyspepsia—Paclitaxel—kidney cancer	3.87e-05	0.000497	CcSEcCtD
Lomitapide—CYP3A4—Xenobiotics—CYP1A1—kidney cancer	3.83e-05	0.00555	CbGpPWpGaD
Lomitapide—Decreased appetite—Paclitaxel—kidney cancer	3.82e-05	0.000491	CcSEcCtD
Lomitapide—Gastrointestinal disorder—Paclitaxel—kidney cancer	3.8e-05	0.000488	CcSEcCtD
Lomitapide—Fatigue—Paclitaxel—kidney cancer	3.79e-05	0.000487	CcSEcCtD
Lomitapide—Diarrhoea—Vincristine—kidney cancer	3.79e-05	0.000486	CcSEcCtD
Lomitapide—Asthenia—Gemcitabine—kidney cancer	3.77e-05	0.000484	CcSEcCtD
Lomitapide—Arthralgia—Capecitabine—kidney cancer	3.77e-05	0.000483	CcSEcCtD
Lomitapide—Chest pain—Capecitabine—kidney cancer	3.77e-05	0.000483	CcSEcCtD
Lomitapide—Myalgia—Capecitabine—kidney cancer	3.77e-05	0.000483	CcSEcCtD
Lomitapide—Constipation—Paclitaxel—kidney cancer	3.76e-05	0.000483	CcSEcCtD
Lomitapide—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—kidney cancer	3.74e-05	0.00048	CcSEcCtD
Lomitapide—Discomfort—Capecitabine—kidney cancer	3.72e-05	0.000478	CcSEcCtD
Lomitapide—Weight decreased—Doxorubicin—kidney cancer	3.7e-05	0.000475	CcSEcCtD
Lomitapide—CYP3A4—Tamoxifen metabolism—CYP1A1—kidney cancer	3.69e-05	0.00534	CbGpPWpGaD
Lomitapide—Dry mouth—Capecitabine—kidney cancer	3.68e-05	0.000473	CcSEcCtD
Lomitapide—Nausea—Dactinomycin—kidney cancer	3.68e-05	0.000473	CcSEcCtD
Lomitapide—Dizziness—Vincristine—kidney cancer	3.66e-05	0.00047	CcSEcCtD
Lomitapide—Infestation NOS—Doxorubicin—kidney cancer	3.65e-05	0.000468	CcSEcCtD
Lomitapide—Infestation—Doxorubicin—kidney cancer	3.65e-05	0.000468	CcSEcCtD
Lomitapide—CYP3A4—Phase 1 - Functionalization of compounds—ALDH1A1—kidney cancer	3.64e-05	0.00527	CbGpPWpGaD
Lomitapide—Feeling abnormal—Paclitaxel—kidney cancer	3.62e-05	0.000465	CcSEcCtD
Lomitapide—Gastrointestinal pain—Paclitaxel—kidney cancer	3.6e-05	0.000462	CcSEcCtD
Lomitapide—Diarrhoea—Gemcitabine—kidney cancer	3.59e-05	0.000461	CcSEcCtD
Lomitapide—Infection—Capecitabine—kidney cancer	3.59e-05	0.00046	CcSEcCtD
Lomitapide—Nervous system disorder—Capecitabine—kidney cancer	3.54e-05	0.000454	CcSEcCtD
Lomitapide—CYP3A4—Biological oxidations—ACY1—kidney cancer	3.52e-05	0.00511	CbGpPWpGaD
Lomitapide—Vomiting—Vincristine—kidney cancer	3.52e-05	0.000452	CcSEcCtD
Lomitapide—Skin disorder—Capecitabine—kidney cancer	3.51e-05	0.00045	CcSEcCtD
Lomitapide—ABCB1—Allograft Rejection—IL13—kidney cancer	3.49e-05	0.00507	CbGpPWpGaD
Lomitapide—Hyperhidrosis—Capecitabine—kidney cancer	3.49e-05	0.000448	CcSEcCtD
Lomitapide—Haematuria—Doxorubicin—kidney cancer	3.48e-05	0.000447	CcSEcCtD
Lomitapide—Abdominal pain—Paclitaxel—kidney cancer	3.48e-05	0.000446	CcSEcCtD
Lomitapide—Body temperature increased—Paclitaxel—kidney cancer	3.48e-05	0.000446	CcSEcCtD
Lomitapide—Headache—Vincristine—kidney cancer	3.47e-05	0.000445	CcSEcCtD
Lomitapide—Hepatobiliary disease—Doxorubicin—kidney cancer	3.45e-05	0.000443	CcSEcCtD
Lomitapide—Sinusitis—Doxorubicin—kidney cancer	3.42e-05	0.000439	CcSEcCtD
Lomitapide—MTTP—Metabolism—CRABP1—kidney cancer	3.4e-05	0.00492	CbGpPWpGaD
Lomitapide—Vomiting—Gemcitabine—kidney cancer	3.34e-05	0.000429	CcSEcCtD
Lomitapide—ABCB1—HIF-1-alpha transcription factor network—SLC2A1—kidney cancer	3.29e-05	0.00477	CbGpPWpGaD
Lomitapide—Headache—Gemcitabine—kidney cancer	3.29e-05	0.000423	CcSEcCtD
Lomitapide—Nausea—Vincristine—kidney cancer	3.29e-05	0.000422	CcSEcCtD
Lomitapide—Musculoskeletal discomfort—Capecitabine—kidney cancer	3.29e-05	0.000422	CcSEcCtD
Lomitapide—Paraesthesia—Capecitabine—kidney cancer	3.24e-05	0.000416	CcSEcCtD
Lomitapide—Urinary tract disorder—Doxorubicin—kidney cancer	3.23e-05	0.000415	CcSEcCtD
Lomitapide—Connective tissue disorder—Doxorubicin—kidney cancer	3.22e-05	0.000413	CcSEcCtD
Lomitapide—Urethral disorder—Doxorubicin—kidney cancer	3.21e-05	0.000412	CcSEcCtD
Lomitapide—Dyspepsia—Capecitabine—kidney cancer	3.18e-05	0.000408	CcSEcCtD
Lomitapide—MTTP—Circadian rythm related genes—TP53—kidney cancer	3.18e-05	0.0046	CbGpPWpGaD
Lomitapide—MTTP—Metabolism—ITPR2—kidney cancer	3.16e-05	0.00458	CbGpPWpGaD
Lomitapide—Asthenia—Paclitaxel—kidney cancer	3.16e-05	0.000405	CcSEcCtD
Lomitapide—Decreased appetite—Capecitabine—kidney cancer	3.14e-05	0.000403	CcSEcCtD
Lomitapide—Nausea—Gemcitabine—kidney cancer	3.12e-05	0.000401	CcSEcCtD
Lomitapide—Gastrointestinal disorder—Capecitabine—kidney cancer	3.12e-05	0.0004	CcSEcCtD
Lomitapide—Fatigue—Capecitabine—kidney cancer	3.11e-05	0.0004	CcSEcCtD
Lomitapide—Constipation—Capecitabine—kidney cancer	3.09e-05	0.000396	CcSEcCtD
Lomitapide—Eye disorder—Doxorubicin—kidney cancer	3.06e-05	0.000393	CcSEcCtD
Lomitapide—Cardiac disorder—Doxorubicin—kidney cancer	3.04e-05	0.00039	CcSEcCtD
Lomitapide—Diarrhoea—Paclitaxel—kidney cancer	3.01e-05	0.000386	CcSEcCtD
Lomitapide—Feeling abnormal—Capecitabine—kidney cancer	2.97e-05	0.000382	CcSEcCtD
Lomitapide—Gastrointestinal pain—Capecitabine—kidney cancer	2.95e-05	0.000379	CcSEcCtD
Lomitapide—Mediastinal disorder—Doxorubicin—kidney cancer	2.95e-05	0.000379	CcSEcCtD
Lomitapide—Chills—Doxorubicin—kidney cancer	2.94e-05	0.000377	CcSEcCtD
Lomitapide—MTTP—Metabolism of lipids and lipoproteins—POMC—kidney cancer	2.91e-05	0.00422	CbGpPWpGaD
Lomitapide—Dizziness—Paclitaxel—kidney cancer	2.91e-05	0.000373	CcSEcCtD
Lomitapide—MTTP—Metabolism—ACHE—kidney cancer	2.88e-05	0.00417	CbGpPWpGaD
Lomitapide—MTTP—Metabolism—GSTT1—kidney cancer	2.88e-05	0.00417	CbGpPWpGaD
Lomitapide—CYP3A4—Constitutive Androstane Receptor Pathway—ABCB1—kidney cancer	2.86e-05	0.00414	CbGpPWpGaD
Lomitapide—Abdominal pain—Capecitabine—kidney cancer	2.85e-05	0.000366	CcSEcCtD
Lomitapide—Body temperature increased—Capecitabine—kidney cancer	2.85e-05	0.000366	CcSEcCtD
Lomitapide—Malnutrition—Doxorubicin—kidney cancer	2.85e-05	0.000366	CcSEcCtD
Lomitapide—Flatulence—Doxorubicin—kidney cancer	2.81e-05	0.000361	CcSEcCtD
Lomitapide—Vomiting—Paclitaxel—kidney cancer	2.8e-05	0.000359	CcSEcCtD
Lomitapide—Back pain—Doxorubicin—kidney cancer	2.76e-05	0.000354	CcSEcCtD
Lomitapide—Headache—Paclitaxel—kidney cancer	2.76e-05	0.000354	CcSEcCtD
Lomitapide—Muscle spasms—Doxorubicin—kidney cancer	2.74e-05	0.000352	CcSEcCtD
Lomitapide—MTTP—Metabolism—SCARB1—kidney cancer	2.73e-05	0.00395	CbGpPWpGaD
Lomitapide—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—kidney cancer	2.72e-05	0.00395	CbGpPWpGaD
Lomitapide—MTTP—Metabolism—PTGS1—kidney cancer	2.7e-05	0.00391	CbGpPWpGaD
Lomitapide—MTTP—Metabolism—PSMD7—kidney cancer	2.65e-05	0.00383	CbGpPWpGaD
Lomitapide—Ill-defined disorder—Doxorubicin—kidney cancer	2.65e-05	0.00034	CcSEcCtD
Lomitapide—Anaemia—Doxorubicin—kidney cancer	2.64e-05	0.000338	CcSEcCtD
Lomitapide—Nausea—Paclitaxel—kidney cancer	2.61e-05	0.000335	CcSEcCtD
Lomitapide—Asthenia—Capecitabine—kidney cancer	2.59e-05	0.000332	CcSEcCtD
Lomitapide—Malaise—Doxorubicin—kidney cancer	2.57e-05	0.00033	CcSEcCtD
Lomitapide—Vertigo—Doxorubicin—kidney cancer	2.56e-05	0.000329	CcSEcCtD
Lomitapide—Palpitations—Doxorubicin—kidney cancer	2.52e-05	0.000323	CcSEcCtD
Lomitapide—MTTP—Metabolism—BCHE—kidney cancer	2.51e-05	0.00364	CbGpPWpGaD
Lomitapide—MTTP—Metabolism—SLC5A5—kidney cancer	2.48e-05	0.00359	CbGpPWpGaD
Lomitapide—Diarrhoea—Capecitabine—kidney cancer	2.47e-05	0.000317	CcSEcCtD
Lomitapide—Myalgia—Doxorubicin—kidney cancer	2.43e-05	0.000312	CcSEcCtD
Lomitapide—Chest pain—Doxorubicin—kidney cancer	2.43e-05	0.000312	CcSEcCtD
Lomitapide—Arthralgia—Doxorubicin—kidney cancer	2.43e-05	0.000312	CcSEcCtD
Lomitapide—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—kidney cancer	2.41e-05	0.000309	CcSEcCtD
Lomitapide—Discomfort—Doxorubicin—kidney cancer	2.4e-05	0.000308	CcSEcCtD
Lomitapide—MTTP—Metabolism—SLC2A1—kidney cancer	2.39e-05	0.00347	CbGpPWpGaD
Lomitapide—Dizziness—Capecitabine—kidney cancer	2.39e-05	0.000306	CcSEcCtD
Lomitapide—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—KIT—kidney cancer	2.38e-05	0.00345	CbGpPWpGaD
Lomitapide—Dry mouth—Doxorubicin—kidney cancer	2.37e-05	0.000305	CcSEcCtD
Lomitapide—MTTP—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	2.32e-05	0.00336	CbGpPWpGaD
Lomitapide—Infection—Doxorubicin—kidney cancer	2.31e-05	0.000297	CcSEcCtD
Lomitapide—Vomiting—Capecitabine—kidney cancer	2.3e-05	0.000295	CcSEcCtD
Lomitapide—Nervous system disorder—Doxorubicin—kidney cancer	2.28e-05	0.000293	CcSEcCtD
Lomitapide—Headache—Capecitabine—kidney cancer	2.26e-05	0.00029	CcSEcCtD
Lomitapide—Skin disorder—Doxorubicin—kidney cancer	2.26e-05	0.00029	CcSEcCtD
Lomitapide—Hyperhidrosis—Doxorubicin—kidney cancer	2.25e-05	0.000289	CcSEcCtD
Lomitapide—Nausea—Capecitabine—kidney cancer	2.14e-05	0.000275	CcSEcCtD
Lomitapide—ABCB1—HIF-1-alpha transcription factor network—HIF1A—kidney cancer	2.13e-05	0.00308	CbGpPWpGaD
Lomitapide—Musculoskeletal discomfort—Doxorubicin—kidney cancer	2.12e-05	0.000272	CcSEcCtD
Lomitapide—Paraesthesia—Doxorubicin—kidney cancer	2.09e-05	0.000268	CcSEcCtD
Lomitapide—Somnolence—Doxorubicin—kidney cancer	2.07e-05	0.000266	CcSEcCtD
Lomitapide—ABCB1—Integrated Pancreatic Cancer Pathway—JUND—kidney cancer	2.05e-05	0.00298	CbGpPWpGaD
Lomitapide—ABCB1—Integrated Pancreatic Cancer Pathway—APAF1—kidney cancer	2.05e-05	0.00298	CbGpPWpGaD
Lomitapide—Dyspepsia—Doxorubicin—kidney cancer	2.05e-05	0.000263	CcSEcCtD
Lomitapide—MTTP—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	2.02e-05	0.00293	CbGpPWpGaD
Lomitapide—Decreased appetite—Doxorubicin—kidney cancer	2.02e-05	0.00026	CcSEcCtD
Lomitapide—Gastrointestinal disorder—Doxorubicin—kidney cancer	2.01e-05	0.000258	CcSEcCtD
Lomitapide—Fatigue—Doxorubicin—kidney cancer	2.01e-05	0.000258	CcSEcCtD
Lomitapide—CYP3A4—Phase 1 - Functionalization of compounds—PTGS1—kidney cancer	2e-05	0.0029	CbGpPWpGaD
Lomitapide—MTTP—Metabolism—GSTP1—kidney cancer	2e-05	0.00289	CbGpPWpGaD
Lomitapide—Constipation—Doxorubicin—kidney cancer	1.99e-05	0.000255	CcSEcCtD
Lomitapide—CYP3A4—Tryptophan metabolism—CYP1A1—kidney cancer	1.97e-05	0.00285	CbGpPWpGaD
Lomitapide—ABCB1—Integrated Pancreatic Cancer Pathway—WT1—kidney cancer	1.95e-05	0.00282	CbGpPWpGaD
Lomitapide—CYP3A4—Biological oxidations—ALDH1A1—kidney cancer	1.93e-05	0.0028	CbGpPWpGaD
Lomitapide—Feeling abnormal—Doxorubicin—kidney cancer	1.92e-05	0.000246	CcSEcCtD
Lomitapide—ABCB1—Transmembrane transport of small molecules—RYR1—kidney cancer	1.91e-05	0.00277	CbGpPWpGaD
Lomitapide—Gastrointestinal pain—Doxorubicin—kidney cancer	1.9e-05	0.000244	CcSEcCtD
Lomitapide—MTTP—Metabolism—ABCB1—kidney cancer	1.89e-05	0.00274	CbGpPWpGaD
Lomitapide—Abdominal pain—Doxorubicin—kidney cancer	1.84e-05	0.000236	CcSEcCtD
Lomitapide—Body temperature increased—Doxorubicin—kidney cancer	1.84e-05	0.000236	CcSEcCtD
Lomitapide—MTTP—Metabolism—GSTM1—kidney cancer	1.83e-05	0.00266	CbGpPWpGaD
Lomitapide—MTTP—Metabolism—CYP1A1—kidney cancer	1.74e-05	0.00252	CbGpPWpGaD
Lomitapide—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—CDKN1B—kidney cancer	1.71e-05	0.00248	CbGpPWpGaD
Lomitapide—ABCB1—Integrated Pancreatic Cancer Pathway—ACHE—kidney cancer	1.69e-05	0.00245	CbGpPWpGaD
Lomitapide—Asthenia—Doxorubicin—kidney cancer	1.67e-05	0.000214	CcSEcCtD
Lomitapide—Diarrhoea—Doxorubicin—kidney cancer	1.59e-05	0.000204	CcSEcCtD
Lomitapide—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—kidney cancer	1.59e-05	0.00231	CbGpPWpGaD
Lomitapide—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—kidney cancer	1.57e-05	0.00228	CbGpPWpGaD
Lomitapide—ABCB1—Integrated Pancreatic Cancer Pathway—ANXA1—kidney cancer	1.56e-05	0.00226	CbGpPWpGaD
Lomitapide—Dizziness—Doxorubicin—kidney cancer	1.54e-05	0.000198	CcSEcCtD
Lomitapide—Vomiting—Doxorubicin—kidney cancer	1.48e-05	0.00019	CcSEcCtD
Lomitapide—Headache—Doxorubicin—kidney cancer	1.46e-05	0.000187	CcSEcCtD
Lomitapide—MTTP—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	1.43e-05	0.00207	CbGpPWpGaD
Lomitapide—ABCB1—Integrated Pancreatic Cancer Pathway—JUNB—kidney cancer	1.4e-05	0.00203	CbGpPWpGaD
Lomitapide—ABCB1—Integrated Pancreatic Cancer Pathway—PAK1—kidney cancer	1.4e-05	0.00203	CbGpPWpGaD
Lomitapide—Nausea—Doxorubicin—kidney cancer	1.38e-05	0.000177	CcSEcCtD
Lomitapide—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—kidney cancer	1.31e-05	0.0019	CbGpPWpGaD
Lomitapide—ABCB1—Integrated Pancreatic Cancer Pathway—EGR1—kidney cancer	1.31e-05	0.00189	CbGpPWpGaD
Lomitapide—MTTP—Metabolism—POMC—kidney cancer	1.3e-05	0.00188	CbGpPWpGaD
Lomitapide—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—kidney cancer	1.29e-05	0.00187	CbGpPWpGaD
Lomitapide—ABCB1—HIF-1-alpha transcription factor network—JUN—kidney cancer	1.28e-05	0.00186	CbGpPWpGaD
Lomitapide—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—kidney cancer	1.19e-05	0.00172	CbGpPWpGaD
Lomitapide—ABCB1—Integrated Pancreatic Cancer Pathway—BRCA2—kidney cancer	1.15e-05	0.00166	CbGpPWpGaD
Lomitapide—ABCB1—Allograft Rejection—IL2—kidney cancer	1.14e-05	0.00166	CbGpPWpGaD
Lomitapide—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN2B—kidney cancer	1.14e-05	0.00165	CbGpPWpGaD
Lomitapide—CYP3A4—Biological oxidations—GSTT1—kidney cancer	1.13e-05	0.00164	CbGpPWpGaD
Lomitapide—ABCB1—HIF-1-alpha transcription factor network—VEGFA—kidney cancer	1.12e-05	0.00162	CbGpPWpGaD
Lomitapide—ABCB1—Transmembrane transport of small molecules—ATP7B—kidney cancer	1.1e-05	0.00159	CbGpPWpGaD
Lomitapide—ABCB1—Transmembrane transport of small molecules—SLC5A3—kidney cancer	1.1e-05	0.00159	CbGpPWpGaD
Lomitapide—ABCB1—Transmembrane transport of small molecules—ANXA2—kidney cancer	1.1e-05	0.00159	CbGpPWpGaD
Lomitapide—CYP3A4—Biological oxidations—PTGS1—kidney cancer	1.06e-05	0.00154	CbGpPWpGaD
Lomitapide—MTTP—Metabolism—PTGS2—kidney cancer	1.03e-05	0.0015	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—ACY1—kidney cancer	9.78e-06	0.00142	CbGpPWpGaD
Lomitapide—ABCB1—Allograft Rejection—VEGFA—kidney cancer	9.71e-06	0.00141	CbGpPWpGaD
Lomitapide—CYP3A4—Phase 1 - Functionalization of compounds—POMC—kidney cancer	9.62e-06	0.00139	CbGpPWpGaD
Lomitapide—MTTP—Metabolism—PTEN—kidney cancer	9.02e-06	0.00131	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—PDHB—kidney cancer	8.32e-06	0.00121	CbGpPWpGaD
Lomitapide—ABCB1—Integrated Pancreatic Cancer Pathway—APC—kidney cancer	8.01e-06	0.00116	CbGpPWpGaD
Lomitapide—CYP3A4—Biological oxidations—GSTP1—kidney cancer	7.87e-06	0.00114	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—CCBL1—kidney cancer	7.82e-06	0.00113	CbGpPWpGaD
Lomitapide—CYP3A4—Metapathway biotransformation—GSTP1—kidney cancer	7.76e-06	0.00112	CbGpPWpGaD
Lomitapide—CYP3A4—Biological oxidations—GSTM1—kidney cancer	7.23e-06	0.00105	CbGpPWpGaD
Lomitapide—CYP3A4—Metapathway biotransformation—GSTM1—kidney cancer	7.13e-06	0.00103	CbGpPWpGaD
Lomitapide—CYP3A4—Biological oxidations—CYP1A1—kidney cancer	6.85e-06	0.000993	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—GLIPR1—kidney cancer	6.78e-06	0.000983	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—PPAT—kidney cancer	6.78e-06	0.000983	CbGpPWpGaD
Lomitapide—CYP3A4—Metapathway biotransformation—CYP1A1—kidney cancer	6.76e-06	0.000979	CbGpPWpGaD
Lomitapide—MTTP—Metabolism—PIK3CA—kidney cancer	6.36e-06	0.000922	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—APRT—kidney cancer	6.3e-06	0.000914	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—FH—kidney cancer	6.3e-06	0.000914	CbGpPWpGaD
Lomitapide—ABCB1—Integrated Pancreatic Cancer Pathway—RAF1—kidney cancer	6.29e-06	0.000911	CbGpPWpGaD
Lomitapide—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—kidney cancer	6.22e-06	0.000902	CbGpPWpGaD
Lomitapide—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—kidney cancer	6.08e-06	0.000882	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—ACY1—kidney cancer	6.03e-06	0.000874	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—GPC3—kidney cancer	5.93e-06	0.000859	CbGpPWpGaD
Lomitapide—ABCB1—Transmembrane transport of small molecules—SLC5A5—kidney cancer	5.79e-06	0.000839	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—CA2—kidney cancer	5.77e-06	0.000836	CbGpPWpGaD
Lomitapide—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1B—kidney cancer	5.76e-06	0.000835	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—ALAD—kidney cancer	5.62e-06	0.000814	CbGpPWpGaD
Lomitapide—ABCB1—Transmembrane transport of small molecules—SLC2A1—kidney cancer	5.59e-06	0.00081	CbGpPWpGaD
Lomitapide—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—kidney cancer	5.5e-06	0.000796	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—ST3GAL2—kidney cancer	5.48e-06	0.000795	CbGpPWpGaD
Lomitapide—ABCB1—Integrated Pancreatic Cancer Pathway—JUN—kidney cancer	5.48e-06	0.000795	CbGpPWpGaD
Lomitapide—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—kidney cancer	5.44e-06	0.000789	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—ALDH1A1—kidney cancer	5.36e-06	0.000777	CbGpPWpGaD
Lomitapide—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—kidney cancer	5.3e-06	0.000769	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—SLC5A3—kidney cancer	5.14e-06	0.000745	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—PGK1—kidney cancer	5.14e-06	0.000745	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—PDHB—kidney cancer	5.12e-06	0.000743	CbGpPWpGaD
Lomitapide—CYP3A4—Biological oxidations—POMC—kidney cancer	5.11e-06	0.00074	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—LDHB—kidney cancer	5.04e-06	0.00073	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—CCBL1—kidney cancer	4.82e-06	0.000698	CbGpPWpGaD
Lomitapide—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—kidney cancer	4.79e-06	0.000694	CbGpPWpGaD
Lomitapide—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK3—kidney cancer	4.53e-06	0.000657	CbGpPWpGaD
Lomitapide—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—kidney cancer	4.41e-06	0.000639	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—CA9—kidney cancer	4.37e-06	0.000633	CbGpPWpGaD
Lomitapide—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK1—kidney cancer	4.31e-06	0.000625	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—PPAT—kidney cancer	4.18e-06	0.000606	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—GLIPR1—kidney cancer	4.18e-06	0.000606	CbGpPWpGaD
Lomitapide—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—kidney cancer	4.07e-06	0.00059	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—APRT—kidney cancer	3.88e-06	0.000563	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—FH—kidney cancer	3.88e-06	0.000563	CbGpPWpGaD
Lomitapide—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—kidney cancer	3.74e-06	0.000542	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—CRABP1—kidney cancer	3.72e-06	0.000538	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—GPC3—kidney cancer	3.65e-06	0.000529	CbGpPWpGaD
Lomitapide—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—kidney cancer	3.62e-06	0.000525	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—CA2—kidney cancer	3.55e-06	0.000515	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—ALAD—kidney cancer	3.46e-06	0.000502	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—ITPR2—kidney cancer	3.45e-06	0.000501	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—ST3GAL2—kidney cancer	3.38e-06	0.00049	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—ALDH1A1—kidney cancer	3.3e-06	0.000479	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—SLC5A3—kidney cancer	3.17e-06	0.000459	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—PGK1—kidney cancer	3.17e-06	0.000459	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—GSTT1—kidney cancer	3.15e-06	0.000457	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—ACHE—kidney cancer	3.15e-06	0.000457	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—LDHB—kidney cancer	3.1e-06	0.00045	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—SCARB1—kidney cancer	2.98e-06	0.000432	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—PTGS1—kidney cancer	2.95e-06	0.000428	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—PSMD7—kidney cancer	2.89e-06	0.00042	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—BCHE—kidney cancer	2.74e-06	0.000398	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—SLC5A5—kidney cancer	2.71e-06	0.000393	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—CA9—kidney cancer	2.69e-06	0.00039	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—SLC2A1—kidney cancer	2.62e-06	0.000379	CbGpPWpGaD
Lomitapide—ABCB1—Transmembrane transport of small molecules—RAF1—kidney cancer	2.5e-06	0.000362	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—CRABP1—kidney cancer	2.29e-06	0.000332	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—GSTP1—kidney cancer	2.18e-06	0.000316	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—ITPR2—kidney cancer	2.13e-06	0.000308	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—GSTM1—kidney cancer	2.01e-06	0.000291	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—ACHE—kidney cancer	1.94e-06	0.000281	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—GSTT1—kidney cancer	1.94e-06	0.000281	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—CYP1A1—kidney cancer	1.9e-06	0.000276	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—SCARB1—kidney cancer	1.84e-06	0.000266	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—PTGS1—kidney cancer	1.82e-06	0.000264	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—PSMD7—kidney cancer	1.78e-06	0.000258	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—BCHE—kidney cancer	1.69e-06	0.000245	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—SLC5A5—kidney cancer	1.67e-06	0.000242	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—SLC2A1—kidney cancer	1.61e-06	0.000234	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—POMC—kidney cancer	1.42e-06	0.000206	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—GSTP1—kidney cancer	1.35e-06	0.000195	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—ABCB1—kidney cancer	1.27e-06	0.000185	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—GSTM1—kidney cancer	1.24e-06	0.000179	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—CYP1A1—kidney cancer	1.17e-06	0.00017	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—PTGS2—kidney cancer	1.13e-06	0.000164	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—PTEN—kidney cancer	9.86e-07	0.000143	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—POMC—kidney cancer	8.74e-07	0.000127	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—PTGS2—kidney cancer	6.97e-07	0.000101	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—PIK3CA—kidney cancer	6.96e-07	0.000101	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—PTEN—kidney cancer	6.08e-07	8.81e-05	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—PIK3CA—kidney cancer	4.29e-07	6.21e-05	CbGpPWpGaD
